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Background:  Type 2 diabetes mellitus (T2DM) has a strong genetic component, and its prevalence is notably increased in the 
family members of T2DM patients. However, there are few studies about the family history of T2DM. We carried out this study 
to assess the influences of family history on clinical characteristics in T2DM patients.
Methods:  This is a cross-sectional study involving 651 T2DM patients. Patient history and physical examination were performed 
and fasting blood was taken. If any first degree relative was diabetic, a family history of diabetes was considered to exist.
Results:  Among the total 621 patients, 38.4% had a family history of diabetes. Patients with a family history had a younger age, 
higher weight, younger age at diagnosis and higher triglyceride level than did those without a family history. Dyslipidemia medi-
cation and metabolic syndrome were more prevalent in familial diabetes. Sex, blood pressure, previous treatment for diabetes, 
HbA1c, C-peptide, total cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol were not differ-
ent between familial and non-familial diabetes. Upon multiple linear regression analysis, the family history of diabetes remained 
significantly associated with serum triglyceride level.
Conclusion:  In T2DM patients with a family history of diabetes, the disease tended to develop earlier. Metabolic syndrome and 
cardiovascular risk factors are more prevalent in familial T2DM than they were in non-familial T2DM. These results support the 
necessity of earlier screening for diabetes in family members of T2DM patients and more active prevention against cardiovascu-
lar disease in T2DM patients with a family history.
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INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a disease characterized by 
increased insulin resistance, decreased beta cell function [1], 
and is known to develop due to various factors. Its prevalence 
has grown continuously around the world, and its complica-
tions have provoked much social and economic loss. Around 
7% of the total world population has T2DM, and the number 
of patients is expected to increase up to 300 million persons by 
2025 [2]. 
  Although prevalence of T2DM is generally high in older 
adults, young T2DM patients are increasingly being reported 
[3]. Many studies on the etiologic factors of T2DM have been 
conducted, and, out of many factors, genetic predispositions 
are found to be important [4,5]. For family history of T2DM, 
insulin resistance and deficiency in insulin secretion tend to 
be inherited by descendants of T2DM patients [6,7], and the 
incidence rate of T2DM becomes higher in said descendants 
[8,9]. In addition, metabolic syndrome, an important risk fac-
tor of diabetes and a predictor of cardiovascular disease [10], 
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was observed to be inherited in some studies [11-13]; howev-
er, there are few studies on its association with a family history 
of diabetes.
  Although many diabetologists have supposed that a family 
history of diabetes has influence on the metabolic aspects of 
patients, only a few studies have been performed on its effects 
on metabolic and clinical factors, except for studies for the in-
fluence of family history of diabetes on T2DM development. 
Therefore, this study aims to determine whether a family his-
tory of diabetes is related to age at diagnosis, cardiovascular, 
factors, and metabolic syndrome in T2DM patients.
METHODS
Participants
This study included 651 T2DM patients (341 males and 309 
females) aged 20 to 70 years hospitalized in Jeju National Uni-
versity Hospital and Konyang University Hospital between 
June 2004 and January 2010. 
  Type 1 diabetes presented by ketoacidosis at diagnosis, se-
rum C-peptide level of < 0.6 ng/mL, or higher anti-GAD anti-
body titer and secondary diabetes caused by medication, pan-
creatic diseases, or endocrine diseases were excluded. Patients 
with a serum creatinine level greater than 2 mg/dL, a leukocyte 
count higher than 10,000/µL, aspartate aminotransferase and 
alanine aminotransferase levels more than three times the up-
per normal limit, and those diagnosed as having malignant tu-
mor were also excluded.
Methods
Detailed medical histories including smoking history, family 
history of diabetes, duration of diabetes, and other associated 
diseases were investigated through patient interviews. Physical 
measurements, as well as and blood and urine tests, were per-
formed using the same standards and methods in each univer-
sity hospital, and their data were prospectively collected. Height 
and body weight were measured with an electronic scale. Waist 
circumference was measured midway between the costal mar-
gin and the iliac crest during mid-respiration with a loosely 
applied tapeline by an investigator sitting next to the standing 
participant with legs spread 25 cm to 30 cm and evenly distrib-
uted body weight. Hip circumference was measured at its widest 
part (greater trochanter). Family history of diabetes was consid-
ered to be present if any first degree relative (parents, brother, 
sister, and child) had diabetes. Fasting blood glucose and other 
blood tests were performed after a 12-hour fast. Total choles-
terol, triglyceride, high density lipoprotein cholesterol (HDL-
C), apolipoprotein B (apoB), apolipoprotein AI (apoAI), cre-
atinine, aspartate aminotransferase, and alanine aminotrans-
ferase were measured with a TBA 200FR (Toshiba, Tokyo, Ja-
pan) in Jeju National University Hospital and with an AU 5400 
(Olympus, Shizuoka-ken, Japan) and a BN ProSpec (Dade Beh-
ring, Marburg, Germany) in Konyang University Hospital. Low 
density lipoprotein cholesterol (LDL-C) was also measured di-
rectly using auto-analyzers. HbA1c was examined with a VARI-
ANT II
TM (Bio-Rad, Hercules, CA, USA) and a Tosoh G7 
(Tosoh Co., Tokyo, Japan) in Jeju National University Hospital 
and in Konyang University Hospital, respectively. C-peptide 
was measured with an Elecsys 2010
TM (Roche, Mannheim, 
Germany).
  Metabolic syndrome was diagnosed based on the criteria of 
the International Diabetes Federation (IDF). Abdominal obe-
sity was defined by the criteria of the Korean Society for the 
Study of Obesity (90 cm for males and 85 cm for females). As 
all participants of this study were diabetic patients, they were 
considered to meet the blood glucose criteria (≥ 100 mg/dL). 
Therefore, metabolic syndrome was diagnosed when a partici-
pant had two or more of the following four factors: 
     1)   Abdominal obesity: waist circumference; male ≥ 90 cm, 
female ≥ 85 cm
     2) Triglyceride ≥ 150 mg/dL 
     3) Blood pressure ≥ 130/85 mm Hg
     4) HDL-C: male < 40 mg/dL, female < 50 mg/dL
Statistical analysis
Statistical analysis was performed with SPSS version 15.0 (SPSS 
Inc., Chicago, IL, USA), and data were presented as mean ± stan-
dard deviation. Means and frequencies of groups were compared 
using Student’s t-test and χ
2 test, respectively. Variables not 
showing a normal distribution, including total cholesterol, tri-
glyceride, HDL-C, LDL-C, apoB, and apoAI were analyzed 
through log conversion, and multivariate analysis was con-
ducted with linear and logistic regression analysis. All P values 
< 0.05 were considered to be statistically significant.
RESULTS
Clinical characteristics
The participants consisted of 341 males and 309 females, and 
their age was 53.8 ± 11.7 years. In total, 38.4% of the study mem-224
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bers had a family history of diabetes. Out of the participants, 
39.1% had hypertension (familial T2DM group, 38.4%; non-fa-
milial T2DM group, 39.7%), and the systolic and diastolic blood 
pressures were 127 ± 16 mm Hg and 78 ± 10 mm Hg, respec-
tively.
  The body weight and body mass index (BMI) were 65.3 ± 
12.6 kg and 24.7 ± 4.2 kg/m
2, respectively, indicating that these 
patients tended to be overweight. The age at diagnosis was 45.3 
± 11.6 years, and the duration of diabetes was relatively long at 
8.4 ± 7.9 years. Their glycemic control was poor, with a HbA1c 
value of 9.6 ± 3.8%.
  Serum creatinine, total cholesterol, triglyceride, and LDL-C 
were 0.9 ± 0.2 mg/dL, 183.6 ± 52.2 mg/dL, 177.4 ± 149.8 mg/
dL, and 114.3 ± 40.8 mg/dL, respectively, which tended to be 
higher than the recommended NCEP-ATP III guideline. Out 
of the total participants, 33.5% were found to have metabolic 
syndrome (Table 1).
Differences in clinical characteristics by family history
The familial T2DM group had a younger overall age, higher 
body weight, younger age at diagnosis, higher blood triglycer-
ide level, and more often took medication for dyslipidemia com-
pared to the non-familial T2DM group. Moreover, the familial 
group recorded higher prevalence of metabolic syndrome. How-
ever, systolic blood pressure, diastolic blood pressure, smoking 
history, HbA1c, C-peptide, total cholesterol, HDL-C, LDL-C, 
apoB, apoAI, and creatinine levels were not significantly differ-
ent between the two groups. In addition, therapeutic modalities 
for diabetes before participation in this study were not different 
between the groups (Table 1).
  To investigate whether family history had significant associ-
ations with various metabolic factors even after adjusting for 
other variables, multiple regression analysis was conducted by 
including age, gender, and other variables showing a signifi-
cant difference in univariate analysis such as body weight, age 
at diagnosis, treatment for dyslipidemia, and family history of 
diabestes. According to multiple linear regression analysis with 
triglyceride level, one of the components of metabolic syndrome, 
as a dependant variable, age, gender, treatment for dyslipid-
emia, and age at diagnosis were not statistically associated, and 
only family history and body weight had a significant influence 
(Table 2). However, regression analysis with body weight and 
metabolic syndrome as dependant variables revealed that there 
was no statistical association with family history of T2DM for 
either variable.
DISCUSSION
A genetic predisposition is known to be a critical factor related 
to the development and clinical characteristics of T2DM. In 
particular, the genetic factor is considered to be important in re-
lation to insulin secretion defect [14], insulin resistance [15,16], 
or both, which are related to early onset of the disease [17,18]. 
Therefore, studies on family history of diabetes are necessary 
to determine the genetic factors of T2DM and to establish ef-
fective preventive measures for high risk groups [19]. 
  T2DM develops at various ages, but its incidence rate, prev-
alence rate, and mortality tend to increase sharply with age [19-
22]. Therefore, age at diagnosis and duration of the disease are 
considered to be very important indexes for determining treat-
ment and prognosis. In this regard, family history of T2DM is 
thought to have a profound impact on age of onset, duration 
of the disease, and other factors. However, until now, there have 
been very few reports about its influence, except for the find-
ing that family history increases the incidence of T2DM. In this 
study, we found that patients with family history were diag-
nosed at younger ages, so the younger age of onset was expect-
ed to lead to longer duration and more complications compared 
to those in patients without family history. From a metabolic 
aspect, the familial T2DM group showed a heavier body weight 
and a higher blood triglyceride level. However, systolic and di-
astolic blood pressures, smoking history, HbA1c, C-peptide, 
total cholesterol, HDL-C, LDL-C, and creatinine were not dif-
ferent between the two groups. Although the treatment rate of 
hypertension was not different between the groups, the familial 
T2DM group received more treatment for dyslipidemia than 
did the other group.
  Metabolic syndrome is a condition that includes several risk 
factors of cardiovascular disease that occur together in an in-
dividual [23], and in patients with metabolic syndrome, inci-
dence rate and mortality of cardiovascular disease are increased 
greatly [24]. Although there are several criteria to diagnose the 
syndrome, the IDF criteria used in this study emphasize the 
importance of abdominal obesity over the other criteria [25] 
since the correlation between obesity and sensitivity to cardio-
vascular disease is known to be high [26]. Actually, patients di-
agnosed with the criteria showed a markedly higher incidence 
rate of cardiovascular disease than did normal persons [26]. 
Some studies have reported no correlation between obesity-
related factors and family history of T2DM [27,28], but others 
[12,29,30] have shown a close relation between obesity and fami-225
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ly history. This current study also found that body weight and 
blood triglyceride level, which are known to be related to obe-
sity and metabolic syndrome, were significantly higher in the 
familial T2DM group. This finding, along with those of other 
studies, suggests that more complications related with meta-
bolic syndrome were expected in T2DM patients with a family 
Table 1.  Baseline characteristics of the study population
Patients with
a family history
Patients without 
a family history 
P value
Number, % 38.4 61.6
Age,  yr 51.8 ± 11.2 54.8 ± 11.7 0.001
Sex,  M/F 131/119 210/190 0.980
a
Body weight, kg 66.6 ± 12.8 64.6 ± 12.5 0.047
Height, cm 162.3 ± 13.9 161.3 ± 14.7 0.410
BMI,  kg/cm
2 25.1 ± 3.6 24.5 ± 4.3 0.097
WC, cm 89.1 ± 11.1 87.9 ± 11.1 0.224
Medication for hypertension, % 45.6 43.6 0.733
a
Medication for dyslipidemia, % 35.2 26.4 0.034
a
SBP, mm Hg 127 ± 15 126 ± 16 0.728
DBP, mm Hg 78 ± 9 78 ± 11 0.765
Smoker, % 28.4 28.4 0.732
a
Duration of T2DM, yr 8.9 ± 7.9 8.0 ± 7.9 0.157
Age at diagnosis, yr 43.4 ± 10.5 46.3 ± 11.7 0.002
A1C, % 9.3 ± 2.5 9.8 ± 4.5 0.090
C-peptide, ng/mL 2.2 ± 1.1 2.4 ± 2.0 0.088
Treatment of T2DM, % 0.061
a
None 16.8 12.6
Lifestyle modification 2.0 1.9
OHA 52.0 46.7
Insulin 8.4 13.4
OHA + insulin 18.0 12.2
BUN, mg/dL 16.7 ± 6.5 17.4 ± 12.9 0.433
Creatinine, mg/dL 0.9 ± 0.3 1.0 ± 0.3 0.439
TC, mg/dL
b 187.2 ± 42.8 181.4 ± 57.2 0.182
TG, mg/dL
b 197.6 ± 164.1 164.6 ± 137.9 0.003
HDL, mg/dL
b 43.9 ± 12.5 45.2 ± 17.1 0.301
LDL, mg/dL
b 115.7 ± 35.9 113.6 ± 43.6 0.539
ApoB, mg/dL
b 93.9 ± 30.3 89.8 ± 31.6 0.134
ApoAI, mg/dL
b 132.3 ± 28.8 133.6 ± 31.3 0.612
Metabolic syndrome, % 39.2 29.9 0.033
a
Values are presented as mean ± standard deviation. 
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; T2DM, type 2 diabetes mellitus; 
A1C, hemoglobin A1C; OHA, oral hypoglycemic agent; BUN, blood urea nitrogen; TC, total cholesterol; TG, triglyceride; HDL, high density 
lipoprotein; LDL, low density lipoprotein; apoAI, apolipoprotein AI; apoB, apolipoprotein B.
aSex, medication for hypertension, medication for dyslipidemia, smoking and treatment for T2DM were analyzed using the χ
2 test, 
bP value was 
expressed after each variable was logarithmically transformed.226
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history of diabetes. In addition, analysis on the metabolic pro-
file related with metabolic syndrome revealed that, although 
blood pressure and HDL-C were not significantly associated 
with family history of T2DM, the prevalence of metabolic syn-
drome was significantly higher in the familial T2DM group. 
Consequently, the higher prevalence rate of metabolic syndrome 
in patients with family history would provoke a higher risk of 
cardiovascular disease. 
  To determine whether family history had a significant asso-
ciation with metabolic factors even after adjustment for vari-
ables like age and gender, multiple regression analysis was con-
ducted using variables found to be significant in univariate 
analysis as dependant variables. Age at diagnosis, body weight, 
and treatment rate of dyslipidemia, which were significant in 
univariate analysis, were included as independent variables in 
addition to age, gender and family history. According to the 
results, a family history of T2DM was significantly associated 
with blood triglyceride level, a variable related with diabetes 
and metabolic syndrome. Metabolic syndrome also did not 
show any statistical significance after the adjustment for other 
factors, probably because the diagnosis of metabolic syndrome 
depended upon various factors, including gender, abdominal 
obesity, and triglyceride, used for the adjustment. The findings 
that metabolic factors such as waist circumference, BMI, and 
duration of diabetes were not significantly associated in uni-
variate analysis, and that body weight was not statistically signif-
icant in multiple regression analysis, may be due to the partici-
pant selection. Patients with diabetes generally have more 
complications and worse health conditions for a longer dura-
tion. However, this study limited the age of the patients to the 
range of 20 to 70 in order to investigate an accurate association 
of family history with waist circumference, abdominal obesity, 
and metabolic syndrome and excluded all patients with a cre-
atinine level greater than 2 mg/dL to avoid confounding fac-
tors such as edema caused by diabetic nephropathy. Because 
patients who were expected to have poor health conditions 
with longer durations of diabetes or complications such as dia-
betic nephropathy were excluded in this study, waist circum-
ference, BMI, and duration may not be significantly different.
  In this study, family history of diabetes was defined as hav-
ing a diabetic patient among one’s first-degree relatives (par-
ents, brother or sister, and child), which was thought to be a 
limitation in accurately quantifying the influence of a genetic 
predisposition. However, previous studies on family history of 
diabetes also defined the family history only with first degree 
relatives [31], and inclusion of relatives more distant than first 
degree could provoke confounding effects, as the disease is very 
common. Therefore, the definition of family history used this 
study could be considered appropriate for the investigation of 
its influence.
  Because this study was cross-sectional and the duration of 
diabetes was long, the results of this study could have limita-
tions with regard to the determination of a causal relationship. 
However, therapeutic modalities for diabetes were not different 
between the two groups, so the difference between the groups 
was considered to be caused by differences in family history it-
self rather than by differences in treatment process or long du-
ration of the disease. Moreover, to investigate a direct relation-
ship between family history and metabolic syndrome, analysis 
including the T2DM patients and non-diabetic participants 
was necessary, but was not conducted in this study. This was 
believed to be a limitation of this study. However, the various 
differences according to family history that were shown in this 
study may be clinically meaningful for the management of 
T2DM patients. In addition, the finding that body weight and 
triglyceride level among the IDF criteria of metabolic syndrome 
were related to family history could be applied usefully in man-
agement of T2DM patients with family history.
  Most previous studies on the family history of diabetes were 
conducted with healthy family members of diabetes patients, 
and there had been no report on family history conducted with 
T2DM patients in Korea. In particular, this study was different 
from previous ones as it investigated differences according to 
family history only with T2DM patients. 
  In conclusion, patients with a family history of diabetes were 
diagnosed at younger ages and they showed a heavier body 
Table 2.  Multiple linear regression analysis for the associa-
tions between triglyceride level and other factors
Independent variable
Triglyceride level
β
a P value
Age -0.009 0.937
Male 0.072 0.879
Body weight, kg 0.167 0.001
Family history of T2DM 0.104 0.026
Age at diagnosis -0.067 0.972
Medication for dyslipidemia 0.055 0.980
Triglyceride level was the dependent variable. 
T2DM, type 2 diabetes mellitus.
aRegression coefficient.227
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weight, a higher blood triglyceride level, and a higher preva-
lence of metabolic syndrome compared to those without a fam-
ily history. These results suggested that family history could af-
fect the development of cardiovascular disease due to a deteri-
orating metabolic profile and early onset of diabetes. There-
fore, different guidelines of treatment and follow-up should be 
applied according to existence of a family history. Patients with 
a family history of diabetes in particular should undergo early 
screening for metabolic syndrome and should take more ac-
tive measures to prevent cardiovascular disease. For example, 
T2DM patients with a family history require lower levels of 
thresholds for cardiovascular risk factor managements, and 
through more in-depth analysis on each criterion, the use of 
anti-platelet agent, anti-hypertensive agent, and treatment for 
dyslipidemia can be started at a relatively young age. In addi-
tion, a large-scaled clinical study is necessary to determine a 
specific screening time for diagnosing diabetes and to make 
management guidelines for the prevention of cardiovascular 
disease for family members of diabetic patients in the future.
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